EIDOS THERAPEUTICS, INC. Interest Expense
EIDOS THERAPEUTICS, INC. reported Interest Expense of $766.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. interest expense for the quarter ending 2020-09-30 was $766.00K.
- EIDOS THERAPEUTICS, INC. interest expense for the quarter ending 2020-06-30 was $604.00K.
- EIDOS THERAPEUTICS, INC. interest expense for the quarter ending 2020-03-31 was $518.00K.
- EIDOS THERAPEUTICS, INC. interest expense for fiscal 2019 was $327.00K, a 67.66% decline from fiscal 2018.
- EIDOS THERAPEUTICS, INC. interest expense for fiscal 2018 was $1.01M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2020-09-30 | $766.00K 10-Q · filed 2020-10-29 | $1.37M derived: sum of 2 quarters · filed 2020-10-29 | $1.89M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $604.00K 10-Q · filed 2020-08-06 | $1.12M 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $518.00K 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | $327.00K 10-K · filed 2020-02-26 | |||
| 2018-12-31 | $1.01M 10-K · filed 2020-02-26 |